Safety and Effectiveness of Molnupiravir (LAGEVRIO(®)) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan

INTRODUCTION: Molnupiravir is an oral antiviral drug that received special approval for emergency use in Japan on December 24 2021 for infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This post-marketing surveillance (PMS) is underway to investigate the safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimata, Masahiro, Watanabe, Asuka, Yanagida, Yukiko, Kinoshita, Daisuke, Maekawa, Shinichiroh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018610/
https://www.ncbi.nlm.nih.gov/pubmed/36928787
http://dx.doi.org/10.1007/s40121-023-00782-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018610/
https://www.ncbi.nlm.nih.gov/pubmed/36928787
http://dx.doi.org/10.1007/s40121-023-00782-5

Ejemplares similares